Dr Daurelio shares her experience on the use of PGT-A in an international webinar

The specialist in reproductive medicine at Instituto Bernabeu analysed the indications of this test and the importance of individualising the treatment for each patient.

Dr Rosa María Daurelio, a specialist in reproductive medicine at Instituto Bernabeu, participated as a speaker in the webinar organised by the Mexican Association of Reproductive Medicine on 18 March 2025.

In this session, Dr Daurelio took part in a panel discussion on the use of PGT-A (Preimplantation Genetic Test for Aneuploidy), where she shared her clinical experience and analysed the indications according to age, history of recurrent miscarriage, recurrent implantation failure (RIF) and the specific profile of each patient.

PGT-A makes it possible to analyse the genetics of the embryo by studying a biopsy of its cells before transfer to the mother’s uterus. This knowledge makes it possible to avoid the transfer of embryos whose chromosomal abnormalities would cause early miscarriage or would not give rise to a healthy baby, as well as to locate and prevent serious diseases caused by genetic alterations in the embryo stage. In this way, healthy offspring can be achieved and the transmission of the disease to future generations can be stopped.

Dr Daurelio’s participation reflects Instituto Bernabeu’s commitment to medical excellence and innovation in personalised fertility treatments.